Ferring, a biopharmaceutical company with its headquarters in Lausanne, Switzerland announced today that Dr. John L. McGuire has been appointed as the President of the Ferring Research Institute…
Ferring founding board member, Dr. Eberhard Zinn died last week; he was 66 years old…
Ferring is exploring the links between recent Nobel Prize winning…
Infertility experts from around the world gather to review the newest breakthroughs including…
The new data was based on a sub-analysis of the landmark trial EISG (European-Israeli Study Group) which was designed to demonstrate non-inferiority of MENOPUR (HP-hMG) when compared with rFSH in nearly 700 IVF and ICSI patients…
The acquisition reinforces Ferring’s commitment to Latin America and strengthens the company in the field of women’s health…
Ferring announced today the closing of a deal with Novartis Pharma AG for the acquisition of the worldwide manufacturing, marketing and distribution rights of NORPROLAC (quinagolide)…
This page is not intended for patients or for members of the general public. It is only intended to be used by healthcare professionals.
OKCette page n'est pas destinée aux patients ou au grand public. Il est uniquement destiné à être utilisé par des professionnels de santé.
OKIk bevestig dat ik een professionele zorgverlener ben of een zakelijke relatie heb met Ferring Pharmaceuticals
OKEz az oldal nem betegeknek, vagy nagyközönségnek szól. Az oldalt kizárólag egészségügyi szakemberek használhatják.
OKTa strona nie jest przeznaczona dla pacjentów ani dla ogółu odwiedzających. Ta strona stworzona jest dla pracowników sektora ochrony zdrowia.
OKЭта страница не предназначена для пациентов или для широкой публики. Она предназначена только для медицинских работников.
OK